Early Rehabilitation After Transfemoral Amputation in Moderately Active Patients

NCT ID: NCT06045468

Last Updated: 2023-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

125 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-05

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Treatment and rehabilitation after transfemoral amputation represents a challenging medical field, involving intersectoral parties. Although treatment guidelines exists, their implementation is difficult. This study is conducted to evaluate the need to practice these guidelines in order to gain best benefits for the patients. Focus is set of early inpatient rehabilitation and the role of a microprocessor-controlled prothesis (Kenevo, Ottobock).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Right after major surgeries, e.g. amputations, inpatient rehabilitation follows in Germany. Costs are covered by different insurances, like public or private health care insurances or German pension insurance. Usually, inpatient rehabilitation lasts for 3 weeks. But after some surgeries, like amputation, patients need more time to recover and fitting of a prosthesis takes additional time. Therefore guidelines state, that rehabilitation should take up to 6-8 weeks after major amputation. To provide evidence to these guidelines, we conducted this study.

Patients' choice on rehabilitation clinic decides on their assignment to the study group or control group. Inpatient rehabilitation is monitored with outcomes measurements. 3 measurements are carried out in the study group within rehabilitational stay of around 6 weeks (admission - middle - discharge) and 2 measurements are carried out in the control group within rehabilitational stay of around 3 weeks (admission - discharge). After discharge from rehabilitation, assessment of patient reported outcome measurements is continued every 6 weeks for both groups. Follow-up phase ends with 24 weeks after admission to rehabilitation.

For subanalysis, different prosthetic devices (non-microprocessor-controlled vs. microprocessor-controlled prosthesis) are compared.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transfemoral Amputation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Non-randomized clinical trial
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

Patients in inpatient rehabilitation in study center.

Group Type EXPERIMENTAL

Amputation-specialized rehabilitation

Intervention Type OTHER

Study center; amputation-specialized unit within rehabilitation facility; fully practicing national guidelines

Control group

Patients in inpatient rehabilitation facility of collaborating clinics.

Group Type EXPERIMENTAL

Non-amputation-specialized rehabilitation

Intervention Type OTHER

Control clinics; treating some amputated patients each year but do not practice national guidelines or partially practicing national guidelines

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Amputation-specialized rehabilitation

Study center; amputation-specialized unit within rehabilitation facility; fully practicing national guidelines

Intervention Type OTHER

Non-amputation-specialized rehabilitation

Control clinics; treating some amputated patients each year but do not practice national guidelines or partially practicing national guidelines

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* inpatient rehabilitation stay after transfemoral amputation or knee disarticulation
* anticipated K-level 1 or 2
* body weight no more than 125kg (authorized body weight for prosthetic device)
* German speaking
* able to give informed consent

Exclusion Criteria

* non-German speaking
* not able to give informed consent
* body weight over 125kg
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Otto Bock Healthcare Products GmbH

INDUSTRY

Sponsor Role collaborator

University Medical Center Mainz

OTHER

Sponsor Role collaborator

Median

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Johannes Schroeter

Director of Orthopaedic clinic

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MEDIAN Clinics

Wiesbaden, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Johannes Schröter, Dr. med.

Role: CONTACT

0049611757811

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Johannes Schroeter, Dr. med.

Role: primary

0049 611 575811

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Kenevo2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.